MedTrace Logo

Endoveneous Histologic Study

NCT03326219 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-11-28

No results posted yet for this study

Summary

A new technique, mechanochemical endovenous ablation (MOCA), using the ClariVein ® system is recently developed. To date, histopathological data after mechanochemical endovenous ablation are not known.

The aim of this study is the histopathological analysis of venous injury using mechanochemical endovenous ablation.

Conditions

  • Varicose Veins

Interventions

PROCEDURE

Clarivein

The Clarivein technique uses mechanical damage to the endothelium of the vein wall through a rotating tip of the catheter. At the same time a sclerosans is injected, causing occlusion of the vein. No heating is used in this technique .

Sponsors & Collaborators

  • Rijnstate Hospital

    lead OTHER

Principal Investigators

  • MMPJ Reijnen, MD · Rijnstate

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03326219 on ClinicalTrials.gov